Trial Profile
Second outcome trial of empagliflozin in patients with chronic heart failure
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 22 Apr 2016 New trial record